West Virginia MPJE (Pharmacy Jurisprudence) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the West Virginia MPJE Exam. Includes flashcards and multiple-choice questions, each with hints and explanations. Prepare effectively for your pharmacy law exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What is the difference between prospective and retrospective DUR, and who performs each?

  1. Prospective DUR is performed by the dispensing pharmacist; retrospective DUR is performed by the pharmacist intern.

  2. Prospective DUR is performed by the prescriber; retrospective DUR is performed by the hospital.

  3. Prospective DUR is evaluating drug therapy prior to dispensing; retrospective DUR is performed by the pharmacist technician.

  4. Prospective DUR is evaluating drug therapy prior to dispensing; retrospective DUR is evaluating drug therapy after dispensing, performed by the state.

The correct answer is: Prospective DUR is performed by the dispensing pharmacist; retrospective DUR is performed by the pharmacist intern.

The distinction between prospective and retrospective Drug Utilization Review (DUR) lies primarily in the timing of the review and the individuals involved in performing these evaluations. Prospective DUR involves an evaluation of a patient's drug therapy before the medication is dispensed. This is typically carried out by the pharmacist to ensure that the prescribed medication is appropriate for the patient, considering factors such as drug interactions, allergies, and therapeutic duplications. The goal is to prevent potential drug-related problems before the patient even receives the medication. Retrospective DUR, on the other hand, is conducted after the medication has been dispensed. This review assesses the appropriateness and outcomes of therapy once the patient has been on the medication for some time. This type of evaluation can be performed by various entities, including pharmacists, insurance companies, or regulatory bodies, as they analyze prescription patterns to improve the overall quality of care and ensure compliance with best practices. The correct response accurately reflects these roles and the timing of each type of DUR. Other options do not align with the established definitions or responsibilities associated with DUR practices.